The present study aimed to prepare and evaluate a controlled-release system based on a chitosan scaffold containing selenium nanoparticles loaded with doxycycline. Its topical application in skin wound healing in rats was investigated. Therefore, 80 female rats were used and, after creating experimental skin defects on their back, were randomly divided into four equal groups: the control group without any therapeutic intervention; the second group received a chitosan transdermal patch (Ch); the third group received chitosan transdermal patch loaded with selenium nanoparticles (ChSeN), and the last group received chitosan transdermal patch containing selenium nanoparticle loaded by doxycycline (ChSeND). Morphological and structural characteristics of the synthesized patches were evaluated, and in addition to measuring the skin wound area on days 3, 7, and 21, a histopathological examination was performed. On the third day of the study, less hemorrhage and inflammation and more neo-vascularization were seen in the ChSeND group. Moreover, on day 7, less inflammation and collagen formation were recorded in the ChSeN and ChSeND groups than in the other groups. At the same time, more neo-vascularization and re-epithelialization were seen in the ChSeND group on days 7 and 21. In addition, on day 21 of the study, the most collagen formation was in this group. Examination of the wound area also showed that the lowest area belonged to the ChSeND group. The results showed that the simultaneous presence of selenium nanoparticles and doxycycline in the ChSeND group provided the best repair compared to the control, Ch and ChSeN groups.
The aim of this study is to compare the histopathological changes in experimental skin wound healing in mice treated with a topical application of chitosan combined with doxycycline, as well as zinc and selenium nanoparticles. Fifty mice with experimental skin wounds were divided into four equal groups: a control group with no therapeutic intervention, a CsD group receiving a transdermal patch containing doxycycline, a CsDZn group receiving a transdermal patch with chitosan-doxycycline-zinc nanoparticles, a CsZnS group receiving a transdermal patch with chitosan-zinc and selenium nanoparticles, and a CsDZnS group receiving a transdermal patch containing chitosan-doxycycline-zinc and selenium nanoparticles. After synthesizing and confirming the efficacy of the transdermal patches, we measured the wound area and histological indices of wound healing on the 7th and 14th days of the study. The results showed that the use of selenium and zinc nanoparticles leads to a decrease in the wound surface in the CsDZnS group compared to the control group and remaining experimental groups. A significant reduction in inflammation and hemorrhage was recorded in the CsDZnS group compared to other groups. On the seventh day of the study, angiogenesis in the CsDZnS group was higher than in the other groups. In addition, on the 14th day of the study, orientation of collagen fibers and re-epithelialization were more observed in the CsDZnS group compared to the other groups. The chitosan skin patch containing doxycycline, zinc nanoparticles, and selenium nanoparticles (CsDZnS group) demonstrated the most effective results in skin healing, as evidenced by the highest control of inflammation on days 7 and 14, the greatest re-epithelialization on day 14, and the smallest wound area on both days compared to the other evaluated groups.